GNAPHALIUM POLYCEPHALUM-INJEEL LIQ (12D,30D,200D/1.1ML) DIN 02058286
Status: Cancelled Post Market
Holder: BIOLOGISCHE HEILMITTEL HEEL GMBH
Molecule: GNAPHALIUM POLYCEPHALUM
Health Canada record
| Active ingredient(s) | GNAPHALIUM POLYCEPHALUM 12 D |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1993 |
| Current status date | 06-Mar-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GNAPHALIUM POLYCEPHALUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00855405 | GNAPHALIUM GRANULES 1DH | HOMEOCAN INC. | Tablet | GNAPHALIUM POLYCEPHALUM 1 DH | Cancelled Post Market |
| 02234521 | GNAPHALIUM POLYCEPHALUM | DOLISOS CANADA INC. | Liquid; Globules; Granules | GNAPHALIUM POLYCEPHALUM 1 X | Cancelled Post Market |
| 00683973 | GNAPHALIUM POLYCEPHALUM GOUTTE 4CH-30CH | DOLISOS LABORATOIRES S.A. | Drops | GNAPHALIUM POLYCEPHALUM 1 CH | Cancelled Post Market |
| 00698334 | GNAPHALIUM POLYCEPHALUM GRANULE 1DH - 30CH | DOLISOS LABORATOIRES S.A. | Tablet | GNAPHALIUM POLYCEPHALUM 1 DH | Cancelled Post Market |